GFRα2 Protein - GDNF Family Receptor Alpha 2

GFRα2 Protein - GDNF Family Receptor Alpha 2

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GFRα2 Protein - GDNF Family Receptor Alpha 2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>GFRA2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>GFRα2 - GDNF Family Receptor Alpha 2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=GFRA2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

GFRα2 (GDNF Family Receptor Alpha 2, encoded by the GFRA2 gene) is a GPI-anchored cell surface receptor that serves as the primary high-affinity receptor for neurturin (NRTN) and other GDNF family ligands. As a member of the GDNF receptor family (GFRα1-4), GFRα2 plays critical roles in neuronal survival, development, and maintenance throughout the lifespan. The GFRα2/RET signaling complex is essential for the neuroprotective effects of neurturin on dopaminergic [neurons](/entities/neurons) and has been extensively studied as a therapeutic target for Parkinson's disease.
title: GFRα2 Protein

GFRα2 Protein - GDNF Family Receptor Alpha 2

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GFRα2 Protein - GDNF Family Receptor Alpha 2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>GFRA2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>GFRα2 - GDNF Family Receptor Alpha 2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=GFRA2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

GFRα2 (GDNF Family Receptor Alpha 2, encoded by the GFRA2 gene) is a GPI-anchored cell surface receptor that serves as the primary high-affinity receptor for neurturin (NRTN) and other GDNF family ligands. As a member of the GDNF receptor family (GFRα1-4), GFRα2 plays critical roles in neuronal survival, development, and maintenance throughout the lifespan. The GFRα2/RET signaling complex is essential for the neuroprotective effects of neurturin on dopaminergic [neurons](/entities/neurons) and has been extensively studied as a therapeutic target for Parkinson's disease.
title: GFRα2 Protein
.infobox.infix-protein
; Protein Name
: GDNF Family Receptor Alpha 2
; Gene Symbol
: [GFRA2](/proteins/gfra2-protein)
; UniProt ID
: [O75711](https://www.uniprot.org/uniprotkb/O75711)
; Molecular Weight
: ~46 kDa (precursor), ~38 kDa (mature)
; Subcellular Localization
: Cell membrane (GPI-anchored), lipid rafts
; Protein Family
: GDNF receptor family (GFRα)
; Ligands
: Neurturin (NRTN), GDNF, ARTN, PSPN

Overview

GFRα2 is a 438-amino acid GPI-anchored protein that functions as a high-affinity receptor for neurturin (NRTN) with a dissociation constant (Kd) of approximately 20 picomolar[@jing1996]. The protein contains an N-terminal signal peptide, three cysteine-rich domains (CRDs), and a C-terminal GPI anchor signal sequence that directs it to the plasma membrane.

Structural Features

N-terminal Signal Peptide (1-20 aa):

• Directs protein to secretory pathway
• Cleaved in the endoplasmic reticulum

• Three homologous CRDs
• Each contains 10 conserved cysteine residues forming disulfide bonds
• CRD2 and CRD3 are primarily involved in ligand binding

• Directs GPI anchoring in the endoplasmic reticulum
• Results in membrane association without transmembrane domain

Isoforms

Multiple GFRA2 isoforms have been identified:

• GFRα2-a: Full-length form expressed in neurons
• GFRα2-b: Truncated form with alternative splicing
• GFRα2-c: Testis-specific isoform

Ligand Binding

Neurturin (NRTN)

Neurturin is a neurotrophic factor belonging to the GDNF family:

• Structure: Homodimeric cysteine knot protein
• Expression: Brain, especially substantia nigra and striatum
• Function: Supports dopaminergic neuron survival

Other Ligands

GDNF (Glial Cell Line-Derived Neurotrophic Factor):

• Primary ligand for GFRα1, lower affinity for GFRα2
• Can cross-activate GFRα2/RET signaling

• Binds GFRα3 preferentially
• Can bind GFRα2 in certain contexts

• Binds GFRα4 preferentially
• Limited binding to GFRα2

Signaling Mechanisms

RET Receptor Tyrosine Kinase

GFRα2 functions as a co-receptor for the RET tyrosine kinase[@baloh1998]:

Ligand Binding: GFRα2-bound neurturin recruits RET to form a tripartite complex

RET Activation:

• Autophosphorylation of tyrosine residues
• Activation of multiple downstream signaling cascades

Downstream Signaling Pathways

PI3K/Akt Pathway:

• Pro-survival signaling
• Anti-apoptotic effects
• Critical for neuronal survival

• Neurite outgrowth
• Neuronal differentiation
• Synaptic plasticity

• Calcium signaling
• Modulation of synaptic transmission

Normal Function in the Nervous System

Dopaminergic Neuron Survival

GFRα2 is essential for neurturin-mediated neuroprotection[@sao2007]:

• Expressed in substantia nigra pars compacta (SNc) dopaminergic neurons
• RET is co-expressed in the same neuronal population
• Neurturin/GFRα2/RET signaling promotes:
• Neuronal survival during development
• Maintenance of dopaminergic phenotype
• Protection from neurotoxic insults

Peripheral Nervous System

In the peripheral nervous system, GFRα2:

• Supports enteric neuron development
• Mediates parasympathetic neuron survival
• Promotes cholinergic neuron maintenance

Synaptic Function

Emerging evidence suggests GFRα2 also functions at synapses:

• Regulates presynaptic terminal function
• Modulates neurotransmitter release
• Influences postsynaptic plasticity

Role in Neurodegenerative Diseases

Parkinson's Disease

GFRα2 is extensively studied in PD context[@gill2003]:

Neuroprotective Potential:

• Neurturin protects dopaminergic neurons from MPTP toxicity
• AAV-neurturin delivery shows promise in PD models
• GFRα2 expression maintained in PD brains

• AAV2-NRTN (CERE-120) trials in PD patients
• Gene therapy approaches targeting GFRα2/RET axis
• Ongoing research into delivery methods

• Anti-apoptotic signaling via PI3K/Akt
• Antioxidant effects
• Support of mitochondrial function

Alzheimer's Disease

GFRα2 may have roles in AD[@murer2001]:

• Expressed in cholinergic basal forebrain neurons
• Potential support of cholinergic neuron survival
• May be affected by AD-related neurodegeneration

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS):

• Motor neuron expression of GFRα2
• Potential neuroprotective effects

• GFRα2 in striatal neurons
• May support medium spiny neuron survival

Therapeutic Implications

Gene Therapy

GFRα2/RET signaling is a prime target for gene therapy:

• AAV-neurturin: Gene therapy delivering NRTN
• AAV-GFRα2: Direct delivery of co-receptor
• RET-optimized constructs: Enhanced signaling

Small Molecule Approaches

• GFRα2 agonists: Develop soluble GFRα2 variants
• RET activators: Small molecule RET activators
• Neurotrophic mimetics: Synthetic neurotrophin analogs

Cell-Based Therapies

• Engineered cells: Cells engineered to express GFRα2/NRTN
• Stem cell approaches: Differentiated neurons with enhanced GFRα2

Research Directions

Unresolved Questions

Experimental Approaches

• Conditional knockout models
• Patient-derived iPSC models
• In vivo imaging of GFRα2 dynamics

See Also

• [GFRA2 Gene](/proteins/gfra2-protein)
• [Neurturin](/proteins/neurturin-protein)
• [GDNF Family](/mechanisms/gdnf-family)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Dopaminergic Neurons](/cell-types/substantia-nigra-pars-compacta-dopamine-neurons)
• [Neurotrophic Factors](/mechanisms/neurotrophic-factors)

External Links

• [GFRα2 Protein - UniProt O75711](https://www.uniprot.org/uniprotkb/O75711)
• [NCBI Gene: GFRA2](https://www.ncbi.nlm.nih.gov/gene/9545)
• [GFRα Family - IUPHAR](https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=571)

Background

The study of Gfrα2 Protein Gdnf Family Receptor Alpha 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References